Ran Li

474 citations
41 papers · 295 indexed · h-index 11
Topics
Growth Hormone and Insulin-like Growth Factors (6 papers)Pituitary Gland Disorders and Treatments (5 papers)Chemotherapy-related skin toxicity (3 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Ran Li

38 papers receiving 292 citations

Peers

Ran Li
Comparison fields: 5 of 83
  • Molecular Biology 61
  • Surgery 54
  • Oncology 43
  • Endocrinology, Diabetes and Metabolism 42
  • Pulmonary and Respiratory Medicine 40
Replace Haiqin Rong with:
Haiqin Rong China
Natalie J Haywood United Kingdom
Sayyed A. Hamidi United States
Man-yin Xu China
Alisa Rachlis Canada
Jialiang Hui China
Ru Gao China
Muriel Del Pino France
Chia-Lo Chang Taiwan
Owen J. MacEneaney United States
Ran Li relative to Haiqin Rong China Haiqin Rong's profile →
Citations per field
00.5×3.5×
Haiqin Rong · 1×
Citations per year

Countries citing papers authored by Ran Li

Since Specialization
Citations

This map shows the geographic impact of Ran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Li more than expected).

Fields of papers citing papers by Ran Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Li. The network helps show where Ran Li may publish in the future.

Co-authorship network of co-authors of Ran Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Li. A scholar is included among the top collaborators of Ran Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Li. Ran Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 4
3 2
4 2
5 0
6 0
7 4
8 6
9 1
10 15
11 6
12 1
13 4
14 8
15 4
16 11
17 12
18 11
19 37
20 9

About Ran Li

Ran Li is a scholar working on Endocrinology, Diabetes and Metabolism, Dermatology and Genetics, having authored 41 papers that have together received 295 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (42 citations), Health, Toxicology and Mutagenesis (31 citations) and Cancer Research (31 citations). Ran Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wei Ma, Jiawei Li, Wenchao Zhang, Ying Zhang, Mingyong Han, Huijuan Zhu, Xiaopeng Guo, Hui Pan, Bing Xing and Hanhui Fu. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026